Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
It’s just another earnings week in the life of pharmaceutical CEOs, with blockbuster expectations running up against cruel reality.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.
In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.
The SEC charged the asset manager with misleading clients over changes to its retirement funds, leading to higher tax bills for investors.
Adoption of the cryptocurrency has outpaced other transformative technologies like the internet and mobile phones.
The chief growth officer is at the forefront of preparing RIAs to grow their businesses and train advisors for the future.